| scholarly article | Q13442814 |
| P2093 | author name string | Akira Kikuchi | |
| Avraham Raz | |||
| Victor Hogan | |||
| Yukinori Takenaka | |||
| Souichi Tsutsumi | |||
| Tatsuo Shimura | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6363-6367 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Galectin-3, a novel binding partner of beta-catenin | |
| P478 | volume | 64 |
| Q35689627 | A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer |
| Q33867523 | A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesis |
| Q36041236 | Analysis of the intracellular role of galectins in cell growth and apoptosis |
| Q41226076 | Astrocyte reactivity after brain injury-: The role of galectins 1 and 3. |
| Q38300891 | Biological applications of a chimeric probe for the assessment of galectin-3 ligands. |
| Q35558837 | Burn control, an adipocyte-specific function for galectin-12. |
| Q39220862 | Cleavage and phosphorylation: important post-translational modifications of galectin-3. |
| Q92763948 | Deciphering the galectin-12 protein interactome reveals a major impact of galectin-12 on glutamine anaplerosis in colon cancer cells |
| Q61903522 | Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity |
| Q36835030 | Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3. |
| Q30319927 | Distinct expression of galectin-3 in pheochromocytomas |
| Q33625906 | Dynamics of galectin-3 in the nucleus and cytoplasm |
| Q38232998 | Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis |
| Q59795305 | Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44 |
| Q35892475 | Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding |
| Q38254055 | Evolving mechanistic insights into galectin functions |
| Q42735222 | Expression of APC protein during tongue malignant transformation in galectin-3-deficient mice challenged by the carcinogen 4-nitroquniline-n-oxide |
| Q64252564 | Extracellular and intracellular small-molecule galectin-3 inhibitors |
| Q36260595 | Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling |
| Q94564009 | Fascin Activates β-Catenin Signaling and Promotes Breast Cancer Stem Cell Function Mainly Through Focal Adhesion Kinase (FAK): Relation With Disease Progression |
| Q34489456 | Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer |
| Q36101399 | Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation |
| Q39250900 | Galectin-1 and Galectin-3 Mediate Protocadherin-24-Dependent Membrane Localization of β-catenin in Colon Cancer Cell Line HCT116 |
| Q47653100 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update |
| Q36343453 | Galectin-3 Immunohistochemical Expression in Thyroid Neoplasms |
| Q39177322 | Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway |
| Q47190193 | Galectin-3 and Cancer Stemness. |
| Q36326176 | Galectin-3 as a Potential Target to Prevent Cancer Metastasis. |
| Q35741579 | Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin |
| Q42730725 | Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer |
| Q40357618 | Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples |
| Q34343335 | Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity |
| Q91674866 | Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma |
| Q24546358 | Galectin-3 regulates myofibroblast activation and hepatic fibrosis |
| Q28535429 | Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma |
| Q57157917 | Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination |
| Q36089958 | Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells |
| Q39684862 | Galectin-3: A novel substrate for c-Abl kinase |
| Q34626339 | Galectin-3: a potential target for cancer prevention. |
| Q38258947 | Galectin-3: an emerging all-out player in metabolic disorders and their complications |
| Q27023534 | Galectin-3: its role in asthma and potential as an anti-inflammatory target |
| Q36742111 | Galectins as modulators of tumor progression in head and neck squamous cell carcinomas |
| Q34381235 | Galectins as modulators of tumour progression |
| Q63979922 | Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities |
| Q28283659 | Galectins: structure, function and therapeutic potential |
| Q36390226 | Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells |
| Q46320321 | Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. |
| Q92212822 | HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer |
| Q46969839 | Hedgehog signaling pathway mediates tongue tumorigenesis in wild-type mice but not in Gal3-deficient mice. |
| Q46888131 | Immunohistochemical and in situ hybridization analysis of galectin-3, a beta-galactoside binding lectin, in the urinary system of adult mice |
| Q37020955 | Immunohistochemical localization of six galectin subtypes in the mouse digestive tract |
| Q50710813 | Importin-mediated nuclear translocation of galectin-3. |
| Q35631729 | Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus. |
| Q38915994 | Inhibition of Wnt/β-Catenin Pathway by Dehydrocostus Lactone and Costunolide in Colon Cancer Cells |
| Q28817295 | Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors |
| Q42367947 | Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors |
| Q36857748 | LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer |
| Q92143839 | LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML |
| Q55308149 | Mice lacking galectin-3 (Lgals3) function have decreased home cage movement. |
| Q39553661 | Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention |
| Q36811564 | New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling. |
| Q90333296 | Non-classical role of Galectin-3 in cancer progression: Translocation to nucleus by carbohydrate-recognition independent manner |
| Q26824889 | Nuclear transport of galectin-3 and its therapeutic implications |
| Q37398525 | Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking |
| Q36667137 | On the role of galectins in signal transduction |
| Q37170854 | P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27. |
| Q37716533 | Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression |
| Q84066530 | Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma |
| Q53599723 | Proteomics study of anthrax lethal toxin-treated murine macrophages. |
| Q33899239 | Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma |
| Q46705680 | Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation |
| Q47133991 | Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis. |
| Q52588202 | Role of MSC-derived galectin 3 in the AML microenvironment. |
| Q34440854 | The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop |
| Q34581026 | The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells. |
| Q42321776 | The inactive form of glycogen synthase kinase-3β is associated with the development of carcinomas in galectin-3 wild-type mice, but not in galectin-3-deficient mice |
| Q28261890 | The roles of Galectin-3 in autoimmunity and tumor progression |
| Q38016538 | The sweet and bitter sides of galectins in melanoma progression |
| Q38485585 | Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. |
| Q37322616 | Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin |
| Q88985377 | USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization |
Search more.